Caffeine, aminoimidazolecarboxamide and dicoumarol, inhibitors of NAD(P)H dehydrogenase (quinone) (DT diaphorase), prevent both the cytotoxicity and DNA interstrand crosslinking produced by 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) in walker cells

This publication has 22 references indexed in Scilit:

• The nitroreductase enzyme in walker cells that activates 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) to 5-(aziridin-1-YL)-4-hydroxylamino-2-nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1.6.99.2)
  Biochemical Pharmacology, 1988
• A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in walker carcinoma cells
  Biochemical Pharmacology, 1988
• DT-diaphorase activity and the cytotoxicity of quinones in C3H/10T1/2 mouse embryo cells
  Biochemical Pharmacology, 1988
• CB 1954 (2,4-dinitro-5-aziridinyl benzamide) becomes a DNA interstrand crosslinking agent in Walker tumour cells
  Biochemical and Biophysical Research Communications, 1986
• Caffeine inhibition of the metabolic activation of a carcinogen, 4-nitroquinoline-1-oxide, in cultured Chinese hamster cells
  Carcinogenesis: Integrative Cancer Research, 1984
• Studies on the protection by imidazoles against the cytotoxicity of the antitumour alkylating agents melphalan and CB 1954
  Biochemical Pharmacology, 1976
• Protection against the effects of the antitumour agent CB 1954 by certain imidazoles and related compounds
  Biochemical Pharmacology, 1975
• Studies on the reversal of the selective antitumour effect of the aziridinyl derivative cb 1954 by 4‐amino‐5‐imidazolecarboxamide
  International Journal of Cancer, 1972
• Serum-mediated Immunological Non-reactivity between Histoincompatible Cells in Tetraparental Mice
  Nature, 1971
• 2,4-Dinitro-5-ethyleneiminobenzamide (CB 1954): A potent and selective inhibitor of the growth of the Walker carcinoma 256
  Biochemical Pharmacology, 1969